Which molecule acts as the primary electron carrier in the Krebs cycle?
Which coenzyme serves as the primary electron acceptor in multiple dehydrogenase reactions of the Kreb's cycle?
What is the total number of dehydrogenases involved in the Krebs cycle?
Which of the following metabolic processes is associated with increased Basal Metabolic Rate (BMR)?
Which of the following primarily occurs in the mitochondria?
Hyperammonaemia inhibits the TCA cycle by depleting which of the following?
Which of the following is the most reactive free radical?
The mechanism of action of uncouplers of oxidative phosphorylation involves:
Which of the following enzyme activity decreases in fasting?
Most abundant source of fuel in starvation -
Explanation: ***NADH*** - **NADH** (reduced nicotinamide adenine dinucleotide) is the **primary electron carrier** produced during the Krebs cycle. - **Three molecules of NADH** are generated per cycle (at isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, and malate dehydrogenase steps). - These high-energy electrons are transferred to the **electron transport chain** to generate approximately **7.5 ATP per NADH**. *NAD+* - **NAD+** (oxidized nicotinamide adenine dinucleotide) is the coenzyme that *accepts* electrons during the Krebs cycle. - It is the **oxidized form** that gets reduced to NADH, not the carrier itself. *FADH₂* - **FADH₂** (reduced flavin adenine dinucleotide) is also produced in the Krebs cycle at the **succinate dehydrogenase** step. - However, only **one molecule of FADH₂** is produced per cycle compared to three NADH molecules. - FADH₂ generates approximately **5 ATP** in the electron transport chain, making NADH the quantitatively dominant electron carrier. *NADPH* - **NADPH** (reduced nicotinamide adenine dinucleotide phosphate) is NOT involved in the Krebs cycle. - It is primarily used in **anabolic pathways** such as fatty acid synthesis, cholesterol synthesis, and the **pentose phosphate pathway**. - NADPH serves as a **reducing agent** in biosynthetic reactions and protects against oxidative stress.
Explanation: ***NAD⁺ (NAD)*** - **NAD⁺ (Nicotinamide Adenine Dinucleotide)** serves as the primary **electron acceptor** in the Kreb's cycle, being reduced to **NADH** in three key dehydrogenase reactions. - These reactions occur at: **isocitrate dehydrogenase**, **α-ketoglutarate dehydrogenase**, and **malate dehydrogenase** steps. - The **NAD⁺/NADH** coenzyme system is essential for extracting energy from acetyl-CoA, with NADH subsequently donating electrons to the **electron transport chain** for ATP synthesis. *NADP* - **NADP⁺ (Nicotinamide Adenine Dinucleotide Phosphate)** is primarily involved in **anabolic reactions**, such as **fatty acid synthesis** and the **pentose phosphate pathway**. - While structurally similar to NAD⁺ (differing only by a phosphate group), it functions in different metabolic pathways and is not utilized in the **Kreb's cycle**. *NADPH* - **NADPH** is the reduced form of **NADP⁺** and functions as a reducing agent in various **biosynthetic pathways**, including synthesis of **fatty acids**, **cholesterol**, and **nucleotides**. - It also plays a crucial role in **antioxidant defense** (glutathione reduction) and the **respiratory burst** in phagocytes. - NADPH is not involved in the **Kreb's cycle**, which uses the NAD⁺/NADH system instead. *NADH* - **NADH** is the **reduced form** of NAD⁺ produced during the Kreb's cycle reactions. - While NADH and NAD⁺ are two forms of the same coenzyme, the question asks for the **electron acceptor** form, which is **NAD⁺** (oxidized form). - **NADH** carries the extracted electrons to **Complex I** of the electron transport chain, where it is reoxidized back to NAD⁺, generating approximately **2.5 ATP** per NADH molecule.
Explanation: ***4*** - There are four major **dehydrogenase enzymes** that catalyze oxidation-reduction reactions in the Krebs cycle. - These enzymes are **isocitrate dehydrogenase**, **α-ketoglutarate dehydrogenase complex**, **succinate dehydrogenase**, and **malate dehydrogenase**. *3* - This count is incorrect as it omits at least one key dehydrogenase involved in the Krebs cycle's oxidative steps. - A count of three would exclude one of the enzymes responsible for generating **NADH** or **FADH2**. *2* - This number is significantly underestimated, as the Krebs cycle involves multiple steps where a substrate is oxidized and a coenzyme is reduced. - Such a low number would fail to account for the multiple points of **NADH** and **FADH2** generation. *5* - This count is incorrect, as there are specifically four well-established dehydrogenase enzymes within the Krebs cycle responsible for the production of **NADH** or **FADH2**. - No additional dehydrogenase beyond the four listed plays a primary role in the canonical Krebs cycle.
Explanation: ***Increased glycolysis*** - Among the given options, **increased glycolysis** is the best answer as it represents **active catabolic metabolism** that generates ATP to meet energy demands. - While glycolysis itself doesn't directly increase BMR, **increased glycolytic activity occurs in metabolically active tissues** and reflects higher cellular energy turnover. - Tissues with higher metabolic rates (muscle, brain, liver) have increased glycolysis to meet their ATP demands, making this the most appropriate choice among the options provided. *Increased body fat store* - **Adipose tissue** is metabolically **less active** than lean tissue (muscle, organs). - Increased body fat typically results in a **lower BMR per unit body weight** because fat tissue has minimal metabolic activity compared to muscle. - Greater fat stores are associated with lower, not higher, metabolic rate. *Increased lipogenesis* - **Lipogenesis** (synthesis of fatty acids and triglycerides) is an **anabolic storage process**. - This process occurs during energy surplus and represents a state of **reduced energy expenditure** relative to energy intake. - Storage processes like lipogenesis are associated with **lower overall metabolic activity**, not increased BMR. *Increased glycogenesis* - **Glycogenesis** (synthesis of glycogen from glucose) is an **anabolic storage process** occurring primarily in liver and muscle. - This represents **energy storage**, not energy expenditure, and occurs during fed states when energy demands are being met. - Storage processes do not increase BMR; they indicate surplus energy being stored for later use.
Explanation: ***Correct Option: ETC*** - The **electron transport chain (ETC)** is a series of protein complexes located **exclusively in the inner mitochondrial membrane**. - It occurs **solely in mitochondria** with no cytosolic component, making it the process that most "primarily" occurs in this organelle. - Its primary role is to generate a **proton gradient** through electron transfer, ultimately producing ATP via **oxidative phosphorylation**. - This is the definitive mitochondrial process among the options. *Ketogenesis* - **Ketogenesis** does occur entirely in the **mitochondrial matrix** of liver cells during fasting or low carbohydrate intake. - While mitochondrial, it is tissue-specific (primarily liver) and metabolically conditional (occurs during fasting states). - It involves synthesis of **ketone bodies** (acetoacetate, β-hydroxybutyrate) from acetyl-CoA. *Urea cycle* - The **urea cycle** is compartmentalized between the **mitochondrial matrix** and **cytosol** of liver cells. - First two steps (carbamoyl phosphate synthetase I and ornithine transcarbamylase) occur in mitochondria. - Remaining steps occur in cytosol, so it is NOT primarily mitochondrial. - Functions to detoxify **ammonia** by converting it to urea. *Steroid synthesis* - **Steroid synthesis** primarily occurs in the **smooth endoplasmic reticulum**. - Only specific steps (e.g., cholesterol side-chain cleavage by CYP11A1) occur in mitochondria. - Most of the steroidogenic pathway is extra-mitochondrial.
Explanation: ***a keto glutarate*** - **Hyperammonemia** leads to the depletion of **α-ketoglutarate** through its amination to form **glutamate** by glutamate dehydrogenase and subsequently glutamine by glutamine synthetase. - The removal of **α-ketoglutarate** from the TCA cycle impairs its ability to produce energy and essential intermediates, contributing to neurological dysfunction in hyperammonemia. *succinate* - **Succinate** is an intermediate in the TCA cycle, but its depletion is not the primary mechanism by which hyperammonemia inhibits the cycle. - The direct consumption of **α-ketoglutarate** for ammonia detoxification is the more direct and significant impact. *malate* - **Malate** is another intermediate in the TCA cycle but is downstream from **α-ketoglutarate**. - Its depletion is a consequence of overall TCA cycle inhibition, not the initial cause mediated by hyperammonemia. *fumarate* - **Fumarate** is also a TCA cycle intermediate and is produced after succinate. - Its levels would be affected by the overall inhibition of the cycle, but it is not the direct target or substrate for ammonia detoxification that depletes the cycle.
Explanation: ***Hydroxyl radical*** - The **hydroxyl radical (•OH)** is the most reactive free radical in biological systems due to its extremely high oxidation potential and short half-life. - It readily reacts with virtually all cellular macromolecules, including **DNA, proteins, and lipids**, causing widespread damage. *Peroxide radical* - The **peroxide radical (ROO•)**, or more specifically the peroxyl radical, is less reactive than the hydroxyl radical, but still significant in lipid peroxidation. - It plays a role in propagating chain reactions of **lipid damage** in cell membranes. *Alkyl radical* - **Alkyl radicals (R•)** are generally formed as intermediates during the abstraction of hydrogen atoms from saturated compounds. - While reactive, they are typically less reactive and less frequently encountered in biological systems compared to oxygen-centered radicals like the hydroxyl radical. *Superoxide radical* - The **superoxide radical (O₂•−)** is a relatively less reactive free radical compared to the hydroxyl radical, but it is the precursor to many other reactive oxygen species (ROS). - It is primarily involved in **initiation of oxidative stress** and can lead to the formation of more damaging species through reactions like the Haber-Weiss reaction.
Explanation: ***Disruption of proton gradient across the inner membrane*** - Uncouplers such as **2,4-dinitrophenol** increase the permeability of the **inner mitochondrial membrane** to protons. - This dissipates the **proton motive force** that is normally used by ATP synthase to produce ATP, leading to the uncoupling of electron transport from ATP synthesis. *Inhibition of ATP synthase* - Inhibitors of ATP synthase directly block the enzyme's activity, preventing the synthesis of ATP while the **proton gradient** remains intact. - This mechanism is distinct from uncouplers, which allow electron transport to continue while dissipating the proton gradient. *Stimulation of ATP synthase* - Uncouplers do not stimulate ATP synthase; rather, their action prevents ATP synthase from effectively utilizing the **proton gradient** for ATP production. - Stimulation of ATP synthase would lead to increased ATP synthesis, which is contrary to the effect of uncouplers. *Blocking electron transport chain complexes* - Inhibitors of the **electron transport chain** (e.g., cyanide, rotenone) directly prevent the flow of electrons, thereby preventing the pumping of protons and the formation of a **proton gradient**. - Uncouplers, in contrast, allow electron transport to proceed but dissipate the proton gradient after it has been established.
Explanation: ***Phosphofructokinase I*** - **Phosphofructokinase I (PFK-1)** activity **decreases** during fasting due to **decreased insulin-to-glucagon ratio**, which reduces **fructose-2,6-bisphosphate (F-2,6-BP)** levels, a powerful allosteric activator of PFK-1. - This reduction in activity slows down **glycolysis**, conserving glucose for critical tissues like the brain and redirecting metabolism toward **gluconeogenesis**. - **PFK-1 is the rate-limiting enzyme of glycolysis**, making its regulation particularly significant in the fasted state. *Hormone sensitive lipase* - **Hormone sensitive lipase (HSL)** activity **increases** during fasting due to elevated **glucagon** and **epinephrine** levels, which stimulate its phosphorylation via **protein kinase A (PKA)**. - This increased activity promotes the breakdown of stored **triglycerides** in adipose tissue, releasing **fatty acids** for β-oxidation and energy production. *Glycogen phosphorylase* - **Glycogen phosphorylase** activity **increases** during fasting, primarily stimulated by **glucagon** and **epinephrine**, leading to the breakdown of **glycogen** stores. - This enzyme is crucial for **glycogenolysis**, providing glucose to maintain blood sugar levels when dietary intake is absent. *Acetyl CoA Carboxylase* - **Acetyl CoA Carboxylase (ACC)** activity also **decreases** during fasting, as it is inhibited by **phosphorylation** mediated by **AMP-activated protein kinase (AMPK)** and **protein kinase A (PKA)**. - This reduction in activity inhibits **fatty acid synthesis**, shifting metabolism towards fatty acid **oxidation** for energy production. - **Note:** While ACC activity does decrease during fasting, **PFK-1** is considered the primary answer as it represents the key regulatory point for **glucose metabolism** (glycolysis vs. gluconeogenesis), which is the central metabolic shift during fasting.
Explanation: ***Adipose tissue*** - **Adipose tissue** stores **triglycerides**, which are hydrolyzed into fatty acids and glycerol to serve as the body's primary energy source during prolonged starvation. - The energy reserve in adipose tissue is significantly larger than glycogen stores, providing **sustained fuel** for days or weeks. *Liver glycogen* - **Liver glycogen** is a readily available source of glucose but is rapidly depleted within **12-24 hours** during starvation. - Its primary role is to maintain **blood glucose levels** for glucose-dependent tissues like the brain. *Muscle glycogen* - **Muscle glycogen** is used primarily for **muscle contraction** and cannot be directly released into the bloodstream to maintain blood glucose levels. - While it's a significant energy reserve for working muscles, it does not contribute to systemic fuel needs during starvation. *Blood glucose* - **Blood glucose** is the immediate circulating fuel, but it is tightly regulated and its levels decrease during starvation as glycogen stores are depleted. - It is not an abundant stored source of fuel but rather a transport form of energy.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free